Virtual trials: welcome to the present
With Covid-19 delivering a great big slap in the face to ongoing and planned studies,...
The impact of Covid-19 on the global clinical supply chain
It goes without saying that the coronavirus pandemic has had an unprecedented impact on economies...
Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
After announcing a partnership to assess the safety of potential Covid-19 drugs, TRHC and Regence...
Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?
Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from...
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Having grown into one of the biggest companies in the biotech sphere since its inception...
Dealing with the unexpected: Covid-19 and risk management
Major global events such as the ongoing Covid-19 pandemic can cause significant problems for clinical...
Blockchain enables machine learning and AI to drive a hyper-efficient trial
What can the blockchain offer to time- and cost-intensive modern clinical trials? Novapeutics CEO Frank...
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab...
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
Alongside Pfizer, Merck, Johnson & Johnson and AstraZeneca, Moderna was recently selected as a Covid-19...
‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks
Hydroxychloroquine, a chloroquine drug, has temporarily been dropped from global WHO trials for Covid-19 treatments...